CurePSP Externally-Led Patient-Focused Drug Development Meeting

On February 6, 2026, CurePSP hosted a virtual Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on progressive supranuclear palsy (PSP). EL-PFDD meetings offer a key opportunity for the U.S. Food and Drug Administration (FDA), product developers, and other stakeholders to hear directly from people impacted by PSP.

More Information and Frequently Asked Questions